---
figid: PMC5368180__fphar-08-00153-g001
figtitle: Nanotechnology-based therapy for prostate cancer
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Lareunionomyces loeiensis
pmcid: PMC5368180
filename: fphar-08-00153-g001.jpg
figlink: /pmc/articles/PMC5368180/figure/F1/
number: F1
caption: Schematic illustration of nanotechnology-based therapy for prostate cancer.
  Prostate cancer epithelial cell (PCEC) targeting nanoparticles are conjugated with
  antibodies against PCEC surface markers and contain traditional chemotherapeutic
  drugs. PCSC targeting nanoparticles are conjugated with antibodies against PCSC
  surface markers and contain self-renewal signaling pathway inhibitors. Combination
  use of the nanotechnology-based standard chemotherapy and PCSC specific chemotherapy
  can eradicate the bulk of the tumor cells and PCSCs at the same time, thus may be
  the most efficacious treatment for prostate cancer.
papertitle: 'Prostate Cancer Stem Cells and Nanotechnology: A Focus on Wnt Signaling.'
reftext: Wei Qin, et al. Front Pharmacol. 2017;8:153.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.901423
figid_alias: PMC5368180__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
redirect_from: /figures/PMC5368180__F1
ndex: 2d6fdd95-dea4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5368180__fphar-08-00153-g001.html
  '@type': Dataset
  description: Schematic illustration of nanotechnology-based therapy for prostate
    cancer. Prostate cancer epithelial cell (PCEC) targeting nanoparticles are conjugated
    with antibodies against PCEC surface markers and contain traditional chemotherapeutic
    drugs. PCSC targeting nanoparticles are conjugated with antibodies against PCSC
    surface markers and contain self-renewal signaling pathway inhibitors. Combination
    use of the nanotechnology-based standard chemotherapy and PCSC specific chemotherapy
    can eradicate the bulk of the tumor cells and PCSCs at the same time, thus may
    be the most efficacious treatment for prostate cancer.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - DHH
  - IHH
  - SHH
  - CTNNB1
  - PSCA
  - FOLH1
  - CD44
  - PROM1
  - Wnt2
  - Pik3cg
  - Akt1
  - Ctnnb1
  - Psca
  - Cd44
  - Prom1
  - Pik3r1
  - cabazitaxel
  - Cancer
---
